Radiation Applications

Radioisotopes / US Company Collects $150M For Commercialisation Of Lutetium-177

By Kamen Kraev
8 July 2021

Shine Medical is building production plants in Wisconsin
US Company Collects $150M For Commercialisation Of Lutetium-177
A computer-generated image of the planned radioisotope facility. Courtesy Shine.
Wisconsin-based Shine Medical Technologies has secured $150m in financing from investors for commercialisation of diagnostic and therapeutic isotope technologies, including fusion-based applications, the company said in a statement.

Want to know more?
Sign up.

Pen Use this content

Tags


Related